bondScoverySTUDIO

Royalty Pharma 2.2% 2030 bond (US78081BAK98)

As of 2026-10-27 · rebuilt daily

https://bondscovery.com/bond/US78081BAK98

Royalty Pharma's 2.2% USD bond maturing 2030-09-02 (US78081BAK98) yields 5.51% to worst as of 2026-10-27. That is 70 bp over the US Treasury curve at the same maturity and 26 bp above the fitted United Kingdom Investment Grade Healthcare & Pharmaceuticals Corporate Bond (USD) curve.

View this bond liveUnited Kingdom Investment Grade Healthcare & Pharmaceuticals Corporate Bond (USD) curve
5%5.5%6%3M12M2Y5Y10Y20Y30Y50Y
Fitted curve (line), the bonds it is fitted on (dots) and this bond (magenta). Click to open it in the interactive chart.

Against its curves

Each curve's fitted yield at this bond's maturity (at its call date, where it is priced to call), and the bond's spread to it.

CurveCurve yieldSpread
US Treasury Yields4.80%+70 bp
Royalty Pharma Bond Yields (USD)5.44%+7 bp
United Kingdom Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (USD)5.25%+26 bp
United Kingdom A–BBB Corporate Bond Yields (USD)5.52%-2 bp
United Kingdom Investment Grade Corporate Bond Yields (USD)5.50%+0 bp
US A–BBB Healthcare & Pharmaceuticals Corporate Bond Yields (USD)5.34%+17 bp
US Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (USD)5.33%+17 bp
US A–BBB Corporate Bond Yields (USD)5.51%-0 bp

The bond

ISINUS78081BAK98
IssuerRoyalty Pharma
Issuer typeCorporate
CountryUnited Kingdom
SectorHealthcare & Pharmaceuticals
CurrencyUSD
Coupon2.2%
Coupon frequencySemiannual
Maturity2030-09-02
Rating bandA+–BBB- (Investment Grade)
Yield to worst5.51%